GDF15 and metabolic syndrome: This aligns with recent observations by Di Vincenzo et al. who reported that SG significantly increased circulating GDF15 levels in patients with obesity but without metabolic syndrome, while patients with metabolic syndrome exhibited higher baseline GDF15 levels that did not further increase post-surgery (Di Vincenzo et al. 2025).